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Abstract
Background:  The Retinoblastoma gene product (Rb) has been shown to regulate the
transcription of key genes involved in cell growth and proliferation. Consistent with this, mutations
in Rb are associated with numerous types of cancer making it a critical tumour suppressor gene.
Its function is conferred through a large multiprotein complex that exhibits a dual function in both
activation and repression of gene targets. In C. elegans, the Rb orthologue lin-35  functions
redundantly with other transcriptional regulators to appropriately specify both vulval and
pharyngeal cell fates.
Results: In C. elegans the intestinal cells must alter their cell cycle from the mitotic cell divisions
typical of embryogenesis to karyokinesis and then endoreplication, which facilitates growth during
larval development. While screening for genes that affect the ability of the intestinal cells to
appropriately make this cell cycle transition during post-embryonic development, we isolated
mutants that either compromise this switch and remain mononucleate, or cause these cells to
undergo multiple rounds of nuclear division. Among these mutants we identified a novel allele of
lin-35/Rb, while we also found that the components of the synMuv B complex, which are involved
in vulval specification, are also required to properly regulate the developmentally-controlled cell
cycle transition typical of these intestinal cells during larval development. More importantly, our
work uncovered a role for certain members of the pathways involved in RNAi in mediating the
efficient transition between these cell cycle programs, suggesting that lin-35/Rb cooperates with
these RNAi components. Furthermore, our findings suggest that met-2, a methyltransferase as well
as hpl-1 and hpl-2, two C. elegans homologues of the heterochromatin protein HP1 are also required
for this transition.
Conclusion:  Our findings are consistent with lin-35/Rb, synMuv and RNAi components
cooperating, probably through their additive effects on chromatin modification, to appropriately
modulate the expression of genes that are required to switch from the karyokinesis cell cycle to
endoreplication; a highly specified growth pathway in the intestinal epithelium. The lin-35/Rb
repressor complex may be required to initiate this process, while components of the RNAi
machinery positively reinforce this repression.
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Background
Multicellular organisms must continuously integrate
information from the developmental program in order to
appropriately coordinate cell divisions with cell fate spec-
ification to generate functional tissues and organs. These
developmental cues often impinge directly on key positive
and/or negative regulators of the cell cycle. Although
other levels of regulation exist, in many cell types the crit-
ical point resides with the decision to execute S phase. Sev-
eral key growth-promoting signal transduction pathways
have been implicated in this decision, most of which act
upon the levels or the activity of cyclin D/CDK4/6 com-
plexes during G1 phase [1]. Perhaps the best characterized
among the many important substrates of this kinase is the
tumor suppressor gene Rb, which was originally identified
as a gene commonly mutated in rare heritable retinoblas-
tomas [2]. Since its initial identification, this gene product
has been implicated in many different types of cancer and
compromise of its function may be one of the most com-
mon events preceding the onset of tumorigenesis [3].
Rb is an important negative regulator of cell growth and
proliferation and orthologues have been identified in
most metazoans from C. elegans to humans and more
recently in plants [2,4-6]. These proteins possess a charac-
teristic "pocket domain" that is required for their essential
tumor suppressor activities. Initially, Rb was described as
a negative regulator of the S-phase specific transcription
factor E2F and through its action maintains the cell in G1
phase. The tumor suppressor function associated with Rb
may, at least in part, be mediated through this important
property. However, our understanding of the role of Rb
and the related pocket proteins has expanded and it
appears that their functions are not confined to regulating
the cell cycle. Rather, the pocket-containing proteins are
now known to play important roles other than in cell
cycle regulation in several developmental contexts in
many different organisms [7-9].
A developmental role of Rb became apparent following
the analysis of Rb -/- mice that died early during embryo-
genesis from various developmental abnormalities which
were difficult to account for solely based on cell cycle
defects [10-12]. Subsequently, Rb was found to associate
with known key transcription factors required for organ
specification, thus confirming the role of Rb in regulating
genes required for other essential cellular processes [9].
The Rb/E2F/DP1 complex not only plays an important
developmental role in mice, but its developmental role is
also conserved in invertebrates. In Drosophila melanogaster,
microarray experiments have revealed that several key
developmental regulators appear to be targets of E2F and
Rb [13].
In C. elegans, lin-35 is the only predicted Rb/pocket pro-
tein orthologue and it acts redundantly with additional
gene products in several developmental contexts [6]. Dur-
ing embryogenesis, lin-35/Rb cooperates with compo-
nents of the ubiquitin conjugation machinery to specify
appropriate pharyngeal morphogenesis [14,15]. Genetic
analysis of vulva development has also shown that lin-35/
Rb is required in the hypodermis rather than in the vulval
cells themselves to suppress the ability of the vulval pro-
genitors to respond to sub-threshold ras signalling thereby
ensuring the correct patterning of the organ [6,16,17].
Because of the redundant pathways that cooperate with
Rb to control these transcriptional outcomes in the vulva,
the mutants in these pathways have been referred to as
synthetic Multivulval or synMuv. At present, three differ-
ent classes of synMuv genes have been characterized based
on their genetic interactions and are referred to as either
synMuv A, B or C, all of which act in parallel to appropri-
ately pattern the vulva [18,19]. lin-35/Rb was initially
characterized as a synMuv B gene, as were the E2F ortho-
logue efl-1 and its binding partner dpl-1 [6,20]. Not unex-
pectedly, many of the synMuv B genes are involved in
various aspects of transcriptional control.
Biochemical and genetic evidence suggests that Rb does
not only sequester E2F transcription factors at the G1
phase of the cell cycle, but it also forms a functional
repressor complex with E2F and its DNA-binding partner
DP, in addition to several other proteins that together
repress the expression of genes at various points during
the cell cycle [21]. The notion that Rb, E2F and DP reside
together in a complex involved in modulating gene
expression was further supported when components of a
functional  myb  transcription factor-containing complex
were identified in Drosophila. Among the associated
polypeptides identified in this complex were the Dro-
sophila synMuv B orthologues, suggesting that these pro-
teins form a functional complex that represses gene
expression in various developmental contexts in different
organisms [22,23]. Further evidence in support of a
repressive function for the Rb complex was provided from
findings that demonstrated that Rb interacts directly with
Suv39h, a methyltransferase specific for lysine 9 on his-
tone 3 [24]. This methylated lysine creates a binding site
for the heterochromatin protein HP1, which promotes
the formation of heterochromatin [25,26]. Therefore, the
tumor suppressor function of Rb proteins may equally
depend on their ability to repress the expression of key
developmental genes in cooperation with E2F and DP, in
addition to its well-characterized role in regulating E2F
activity for the expression of the repertoire of genes asso-
ciated with the onset of S-phase.
In C. elegans, the lin-35/Rb complex was demonstrated to
regulate cell division in the intestinal lineage by cooperat-BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
Page 3 of 16
(page number not for citation purposes)
ing with cki-1/-2, two cyclin-dependant kinase inhibitors
[27,28]. However, it was not clear at what level lin-35/Rb
was required, particularly since the intestinal cells
undergo 3 different invariant cell divisions during their
development. Since these transitions are under develop-
mental control, we conducted a forward genetic screen to
identify genes involved in determining appropriate transi-
tions between these different cell cycles typical of the
intestine during post-embryonic development of C. ele-
gans. We identified several mutants, one of which results
from a mutation in lin-35/Rb that affects the ability of the
intestinal cells to initiate endocycles at the appropriate
time during development. In addition to the canonical
transcriptional regulators that constitute the synMuv B
family, we also found that met-2, a predicted methyltrans-
ferase, and hpl-1 as well as hpl-2, two heterochromatin
protein-like (hpl) that bind methylated histone, also
enhance the lin-35  mutant phenotype in the intestine.
Our data are consistent with lin-35/Rb and its associated
synMuv B partners being involved in the regulation of
gene expression associated with this cell cycle transition.
Moreover, further genetic analysis indicated that the Rb
pathway interacts genetically with components of the var-
ious RNAi pathways, suggesting that these pathways func-
tion additively to regulate the expression of key genes that
underlie this developmentally-regulated cell cycle transi-
tion. Taken altogether our data provide a link between the
synMuv B repressor complex, the RNAi pathways, and
chromatin modification in regulating this developmen-
tally-controlled cell cycle transition during post-embry-
onic development.
Results and Discussion
The intestinal cells of C. elegans execute three different
types of cell cycle to give rise to a functional gut in the
growing larva. During embryogenesis, the E blastomere
undergoes 5 successive rounds of mitotic division which
are controlled by both positive and negative cell cycle reg-
ulators that are contributed maternally [29,30]. Following
embryogenesis, the intestine is highly differentiated and
functional to allow the animal to ingest nutrients and
therefore initiate larval development. However the larva,
as well as the intestinal cells, must continue to grow as the
animal progresses through post-embryonic development.
This represents a fundamental problem for the animal, as
terminal differentiation and cell proliferation are gener-
ally mutually exclusive cellular states. To circumvent this,
the cells execute a single nuclear division during the first
larval stage and then execute "endocycles", where they
fully duplicate their genome without undergoing cytoki-
nesis in order to coordinate their growth with the feeding
larva, while still maintaining a fully differentiated and
functional gut.
Using an intestinal-specific GFP marker (elt-2::GFP) to
isolate mutants with an aberrant number of intestinal
nuclei we have previously shown that appropriate activity
of  cki-1, the C. elegans p21/27-like cyclin dependent
kinase inhibitor and the positive S-phase regulator cdc-
25.1 are critical to control cell divisions in the intestinal
cells during embryogenesis, without any effect on the
post-embryonic nuclear divisions or endocycles [29,30].
In a similar screen performed to identify genes involved in
the post-embryonic cell cycle transitions we isolated five
mutants that either possess fewer intestinal nuclei than
wild-type (rr42, rr43 and rr44, class 1 mutants), or more
than the wild-type complement of intestinal nuclei (rr33
and rr45, class 2 mutants) (Figure 1A). Initial characteri-
zation of these mutants indicated that they all exhibit a
maternal effect, with the exception of rr45. The mutants
that give rise to extra intestinal nuclei, rr33 and rr45, are
temperature sensitive and produce only a few eggs before
they become sterile when transferred to restrictive temper-
ature (25°C). Some of these embryos hatch, but these lar-
vae arrest post-embryonic development before the L2
stage. Both class 1 and 2 mutants hatch with the wild-type
number of intestinal cells (20 cells) (Table 1), indicating
that these mutations do not affect embryonic divisions,
unlike cki-1 or cdc25.1(gf), but they specifically affect the
post-embryonic nuclear divisions.
The presence of two classes of mutants prompted us to
examine the genetic interactions between these different
alleles. First, we found that rr33 and rr45 double mutants
are synthetically lethal, suggesting that the genes affected
in these two mutants are part of the same essential cellular
process, or that they affect two parallel but inter-depend-
ent pathways [31]. We also found that class 1 mutations
(less intestinal nuclei than wild-type) suppress both class
2 mutations (more intestinal nuclei-rr33 and rr45), albeit
to different degrees suggesting that the genes encoded by
class 1 mutations may be epistatic to those of class 2 (Fig-
ure 1B). Although at present we have not uncovered the
molecular identity of these mutated genes, the phenotype
of class 1 mutants strongly resembles that of gene prod-
ucts involved in the LIN-5 complex [32]. The LIN-5 com-
plex is required during the first cell division to generate
force at the mitotic spindle. However, the intestinal cells
in hypomorphic alleles of lin-5 mutant are not able to per-
form the nuclear division at the L1 stage and remain
mononucleate. Consistent with this, we found that lin-5 is
also epistatic to rr33, much like our class 1 mutants (Fig-
ure 1B). At present, our mapping data indicate that these
mutations do not correspond to any of the known lin-5
complex components (Table 1). Therefore our class 1
mutants may be implicated in a previously undescribed
lin-5/GPR-related pathway(s) for generating force
required for the nuclear divisions that occur in the intes-
tine during the first larval stage (L1).BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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rr33 is a mutation in the Retinoblastoma (Rb) gene 
orthologue lin-35
The class 2 mutants rr33 and rr45 have similar phenotypes
that include supernumerary intestinal nuclei that arise
postembryonically. We mapped the rr33 mutation to a
small interval on chromosome I (Figure 2A), while rr45
maps to chromosome IV. Using the feeding RNAi library
we tested all the predicted genes in the region to identify
candidates, which upon loss-of-function, would pheno-
copy the rr33  mutant phenotype in wild-type animals
[33]. Only C32F10.2(RNAi), which corresponds to the C.
elegans Rb orthologue lin-35, fully phenocopied the rr33
mutant phenotype when fed to otherwise wild-type ani-
mals. LIN-35 is the only pocket protein predicted within
the C. elegans genome and it was initially identified due to
its role in vulva development as a member of the synMuv
B class of genes [6]. Mutations in synMuv B genes cause a
multivulval (Muv) phenotype only when combined with
a class A or C synMuv mutation [18,19].
We sequenced lin-35/Rb amplified from the rr33 mutant
and found a GC to AT transition at nucleotide 442, which
changes the codon from TGG to TAG, thereby introducing
a premature amber stop codon (Figure 2B). To confirm
that rr33 was indeed an allele of lin-35, we tested it in
combination with lin-8(n111) a known class A synMuv
mutant [34]. Although both mutant backgrounds on their
own have no visible vulva defects, all of the rr33;  lin-
8(n111)  double mutants show the synMuv phenotype
(data not shown). Furthermore, the rr33 phenotype in the
intestine and the lethality at 25°C are both fully rescued
using a functional lin-35::GFP translational fusion protein
(see below and data not shown) [17]. Therefore, based on
RNAi data, sequence analysis of the rr33 mutation, trans-
formation rescue, as well as its ability to produce a syn-
Muv phenotype, we conclude that rr33 is a novel allele of
lin-35 and will be herein referred to as lin-35(rr33).
Previous findings showed that the reference allele lin-
35(n745) had no intestinal nuclear division phenotype
alone, but acted synergistically with cki-1/cki-2 to give rise
to extra intestinal cells/nuclei [27,28]. However, this does
not seem to be the case as both the reference allele lin-
35(n745) and this novel allele lin-35(rr33) increase the
number of intestinal nuclei quite substantially above the
wild-type complement in the absence of any other back-
ground mutation (Figure 1B) [35]. Furthermore, this phe-
notype is not likely the cause of second site mutations as
similar increases in the number of intestinal nuclei have
been observed when both of these mutations are crossed
into different genetic backgrounds ([35], and data not
shown).
Although it was originally reported that lin-35  single
mutants exhibit few visible phenotypes other than a
Two classes of mutants with altered numbers of intestinal  nuclei Figure 1
Two classes of mutants with altered numbers of intestinal 
nuclei. (A) Shows a wild-type (upper panel), a class 1 mutant 
with fewer than the wild-type number of intestinal nuclei 
(rr44) (middle) and class 2 mutant with extra intestinal nuclei 
(lin-35(rr33)) (lower panel). All animals were at the L4 larval 
stage and express the intestinal-specific elt-2::GFP. Anterior is 
left in all pictures. (B) Genetic interaction between the class 
1 and class 2 mutants. All mutants with less intestinal nuclei 
(class 1) are epistatic to the mutants with supernumerary 
nuclear divisions (class 2). The double mutant lin-35(rr33); 
rr45 is synthetic lethal, therefore it is not represented on this 
graph. (C) Lineage analysis of the intestinal cells in lin-35(rr33) 
mutants. The diagram is representative of observations col-
lected from 8 independent larvae from the initiation of post-
embryonic development up to the end of the L2 stage. Hori-
zontal lines represent intestinal nuclear divisions, while the 
vertical lines represent time.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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reduction in fertility, we find that lin-35 is an essential
gene. We found that both lin-35(rr33) and the previously
described reference allele lin-35(n745) arrest post-embry-
onic development at 25°C before they reach adulthood
when upshifted at the L1 stage (data not shown), while
upshifting at the L4 stage results in adults with a low
brood size (average of 66.1 ± 20.8 progeny compared to
169 ± 27 in wild-type, while 38.7% ± 16.9 of these
embryo arrest embryonically in lin-35(rr33) mutant, n =
10 animals). The few embryos that hatch at 25°C arrest
post-embryonically before they reach the L2 stage.
The phenotypic differences observed for lin-35 mutants
reared at 20°C vs 25°C prompted us to question if lin-
35(rr33) is indeed a null allele, despite the stop codon
that it introduces early in the coding sequence. However,
classical tests could not be performed because no deficien-
cies are currently available that uncover the lin-35 locus.
The presence of a stop codon motivated us to look at the
abundance of the mRNA, as aberrant transcripts are usu-
ally degraded by nonsense mediated decay [36]. Using
semi-quantitative RT-PCR, we were able to detect lin-35
mRNA in lin-35(rr33) mutants at levels comparable to
wild-type (data not shown). This result suggests that even
if the rr33 mutation introduces a stop codon, the mRNA
is not degraded through the nonsense mediated decay
pathway. Also, even if the reference allele of lin-35, n745,
also introduces a stop codon at the same position (opal
rather than the amber stop found in rr33), the intestinal
phenotype is more pronounced in lin-35(n745)  com-
pared to lin-35(rr33) (56.3 ± 4.7, n = 21 intestinal nuclei
compared to 50.7 ± 4.7, n = 38 respectively). This differ-
ence between these two alleles is likely due to the varying
capacity of readthrough associated with the two different
stop codons. In support of this, we can recapitulate the
embryonic lethality typical of both alleles when main-
tained at 25°C by injecting lin-35 dsRNA in a lin-35(rr33)
mutant reared at permissive temperature (40.5 ± 21.1 %
embryonic lethality compared to 2.2% embryonic
lethality in uninjected lin-35(rr33) mutant, n = 10). Our
data therefore suggest that lin-35 is an essential gene and
neither of these alleles act as null mutations at 20°C, pre-
sumably due to readthrough.
It was recently shown that lin-35/Rb and probably all the
other components of the synMuv B complex are required
in the hypodermal cells rather than in the vulva cells to
prevent inappropriate ras activation [16,17]. Because of
this cell non-autonomous effect of lin-35/Rb in the vulva
cells, we wanted to test if lin-35 is required autonomously
in the intestinal cells to regulate this cell cycle transition.
To address this we expressed a rescuing lin-35 cDNA spe-
cifically in the intestinal cells using the elt-2 promoter in a
lin-35(rr33) mutant background. We observed that ani-
mals that carry the transgene have 32.6 ± 2.8 intestinal
nuclei compared to 29.3 ± 1.8 for wild-type. Therefore
unlike its role during vulval development, lin-35 activity is
required autonomously within the intestinal cells to con-
trol the intestinal cell cycles characteristic of the L1 stage.
lin-35 is required for the timely initiation of endocycles
The intestine of a wild-type adult C. elegans hermaphro-
dite is composed of 32 nuclei divided among 20 cells due
to a single round of nuclear division that occurs in the first
larval stage (L1). In contrast, the lin-35(rr33) mutant adult
intestine possesses ~50 intestinal nuclei. This defect does
not occur embryonically since mutant larvae hatch with
the normal complement of intestinal cells/nuclei (Table
1). Therefore we performed lineage analysis on lin-
35(rr33) mutants to determine when these extra intestinal
nuclei arise during post-embryonic development. We
found that in lin-35(rr33) mutants the L1-specific nuclear
divisions that occur in intestinal rings 3–9 (Int3-9) are
essentially identical to wild-type and the intestinal cells
become binucleate (Figure 1C). However, lin-35(rr33)
mutants undergo a supernumerary round of nuclear divi-
Table 1: Characterization of class1 and 2 mutants with altered numbers of intestinal nuclei.
Class 1
Genotype Number of nuclei Genetic Map location
L1 Adult
rr421 20 ± 1 21 ± 1 Recessive, maternal LG V, btwn 2.52–2.66
rr431 20 21 ± 2 Recessive, maternal LG V, btwn 2.52–2.66
rr44 19 ± 1 21 ± 2 Recessive, maternal LG I, btwn 2.2–2.6
Class 2
rr33 20 50 ± 5 Recessive, maternal LG I, 0.36 MU
rr45 20 35 ± 6 Recessive, zygotic LG IV, 3.46 MU
1 Complementation tests indicates that rr42 and rr43 are allelic.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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sion in the posterior intestinal cells in the early L2 stage,
just after the normal onset of the endocycle program.
However, not all the intestinal cells execute this division
(on average, 48.9% of the intestinal cells in each animal
are abnormal, n = 20 animals) and there is no bias for any
single cell to divide. Moreover, whereas the cells of the
Int2 ring never undergo nuclear division in wild-type,
these cells will often execute a nuclear division at the L2
stage to become binucleate in the lin-35(rr33)  mutant
background, wherein 22.9% of the lin-35(rr33)  had at
least one divided Int2 cell (n = 20). We interpret these
observations to indicate that affected intestinal cells are
unable to make the timely transition to endocycles at the
L2 molt due to sub-threshold levels of lin-35/Rb, thus
compromising the appropriate downregulation of specific
gene activities. As such, the affected cells undergo an extra
round of nuclear division to eventually possess supernu-
merary intestinal nuclei.
Previously, lin-35 was found to cooperate with cki-1/2 to
regulate intestinal nuclei numbers in the adult [27,28].
However, the presence of extra intestinal nuclei at the
Mapping and cloning of the rr33 mutant Figure 2
Mapping and cloning of the rr33 mutant. (A) SNP-SNIP mapping as well as three-factor mapping approaches were used to map 
rr33 to the center of linkage group I, close to dpy-5. This region contains several well-defined free-duplications of which hDp61 
rescued the rr33 mutant (+) whereas hDp41 did not (-). C32F10.2(RNAi) phenocopies the rr33 mutant phenotype. (B) A sche-
matic representation of the C32F10.2 lin-35/Rb gene with black boxes representing the predicted pocket binding domains and 
the gray box indicating the 3' UTR. The location and the precise nucleotide changes in rr33 and n745 allele are indicated by 
arrows.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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adult can be due to both supernumerary mitotic divisions
during embryogenesis or nuclear divisions during post-
embryonic development. To confirm that indeed cki-1
and lin-35 are acting in two distinct developmental proc-
esses, we inactivated cki-1 by RNAi in wild-type and lin-
35(rr33) mutant backgrounds and scored the number of
intestinal nuclei at both the L1 and adult stage. As previ-
ously reported, cki-1(RNAi) worms hatch with an average
of 30 intestinal cells, comparable to the number of intes-
tinal cells in lin-35(rr33); cki-1(RNAi) (table 2) [30]. This
confirms our lineage analysis indicating that lin-35 does
not play a role during the embryonic mitotic divisions
and does not act in a linear or a parallel pathway with cki-
1 to control mitotic cell divisions in the intestine during
embryogenesis. Therefore, although the loss of both cki-1
and lin-35 results in considerably more intestinal nuclei in
the affected adult animals, this is due to their independent
genetic functions in two clearly distinguishable cell cycle
processes that occur at distinct times in development
[27,28] (Table 2).
Components of the Rb repressor complex cause 
abnormalities in the intestinal nuclear divisions
Current models for Rb family function have classed these
proteins as negative regulators of the G1/S phase transi-
tion of the cell cycle through their ability to sequester tran-
scription factors important for DNA replication such as
E2F [37-40]. This interaction is reversed by Rb phosphor-
ylation mediated by cyclin D-CDK4/6 and/or cyclin E/
CDK2 activity [41,42]. However, it has been shown that
Rb and E2F/DP can form a complex that associates with
known transcriptional repressor components such as his-
tone deacetylases to negatively regulate gene expression
[23,43,44]. The recently identified components of this Rb-
containing repressor complex in Drosophila have homo-
logues in human and C. elegans and most of these gene
products correspond to members of the C. elegans synMuv
B family [22,23].
Because of this duality of Rb function, lin-35 might be
required to prevent the E2F/DP complex from activating S
phase specific genes and therefore block nuclear division
in the intestinal cells. Alternatively, the LIN-35/E2F/DP
repressor complex could act as it does in the vulva cells
where it is required to block gene expression [6,20], and
in the intestine it would repress the expression of key
genes involved in the transition to endocycles. To test
these possibilities we performed efl-1(RNAi) and dpl-
1(RNAi) to compromise the E2f and DP orthologues in C.
elegans, both of which are components of the synMuv B
family [20]. Inactivation of both genes through RNAi
enhances the intestinal division phenotype of lin-35 (Fig-
ure 3A and 3C). Because limiting levels of LIN-35 are
probably still present in the lin-35(rr33)  mutant, our
results suggest that the activity of this complex is even fur-
ther reduced when either efl-1 or dpl-1 are compromised.
This would explain how E2F/DP act additively with lin-35
to appropriately block nuclear divisions in the intestinal
cells at the time they begin to endoreplicate.
To test the importance of the synMuv B complex in regu-
lating this cell cycle transition we performed RNAi against
other components of the synMuv B repressor complex and
found that all of the synMuv B genes tested enhanced the
lin-35(rr33) intestinal nuclei phenotype in a manner sim-
ilar to efl-1 and dpl-1 (Figure 3A). In lin-35(rr33); synMuv
B(RNAi) animals many of the affected cells underwent
several rounds of intestinal nuclear division to give rise to
multinucleate cells that contained more than 4 extra
nuclei (Figure 3C and 3D). Control RNAi using genes that
are not involved in the synMuv B pathway did not induce
any change in the number of intestinal nuclei above the
levels observed in lin-35(rr33) mutants alone (nhr-2 and
sel-1 in Figure 3A and 3D respectively). We conclude that
the synMuv B genes cooperate with lin-35 to control the
timing of the onset of endocycles, and in their absence the
intestinal nuclei undergo repeated rounds of division to
eventually give rise to multinucleate intestinal cells.
Not only do the synMuv B components act cooperatively
with lin-35 to regulate this cell cycle transition, but the
reduction of function of these genes alone in a wild-type
background causes abnormalities typical of the lin-35
nuclear division phenotype, albeit their penetrance and
severity is attenuated (Figure 3B). Based on our data and
current models of how the Rb regulates gene expression,
LIN-35 may act as the core component of a repressor com-
plex that nucleates components of the synMuv B family.
The synMuv B components of this Rb repressor complex
are important for full activity, but they are individually
dispensable. Therefore, the LIN-35/Rb repressor complex
can still silence gene expression even in their absence,
although not as efficiently as the wild-type complex.
lin-35/Rb is required for the repression of cyclin E
Previously, lin-35(n745) was shown to suppress the cell
cycle defects associated with mutations in cyd-1 and cdk-4/
6 [27]. Because the lin-35 complex is required for tran-
scriptional repression of specific genes, we wanted to
determine if the observed effects were a consequence of an
increase of cyclin E or cyclin A levels (cye-1  and cya-1
respectively in C. elegans). These two cyclins are known to
act downstream of cyclin D and the upregulation of these
genes in the lin-35 mutant could potentially compensate
for the loss of cyclin D. Consistent with this hierarchy, we
found that the extra nuclear divisions of the lin-35(rr33)
mutant are suppressed following cye-1(RNAi) (data not
shown). In order to test this hypothesis, we performed
quantitative (q)RT-PCR to determine if any differences in
the levels of A, B, D and E type cyclins were detectable inBMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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wild-type vs lin-35(rr33) mutants. We observed a signifi-
cant decrease in both cyclin B2 variants in the lin-35(rr33)
mutant background compared to wild-type (Figure 4A).
We also found that cyclin E showed a 2-fold upregulation
in lin-35(rr33) mutants (Figure 4A). Cyclin E levels must
be tightly regulated to permit only one round of origin fir-
ing while providing a cyclic burst of CDK2 activity coinci-
dent with the G1/S phase transition [45]. It is therefore
quite possible that coupling of the upregulation of cye-1
with the observed decrease in B2 cyclins may explain the
basis of the supernumerary nuclear divisions and the
aberrant ploidy observed in lin-35(rr33) intestinal cells
(see below) [46].
Recent findings indicate that the Rb complex regulates
both cell proliferation as well as endoreplication in
mouse trophoblasts and in developing leaves, meristems,
and pericycle cells in plants [47-49]. We therefore quanti-
tated the DNA content of the intestinal cells in lin-
35(rr33)  animals to determine if the supernumerary
nuclei typical of lin-35(rr33) were also associated with an
extra full round of DNA replication. If this is the case, the
mutant intestinal nuclei should all have a quantized DNA
content. This is not the case as we found that the ploidy of
the mutant intestinal nuclei in lin-35(rr33) ranges from
4C to 26C compared to 32C in wild-type. This result indi-
cates that by disrupting lin-35 function, correct genome
duplication is compromised and the ploidy of the result-
ing daughter nuclei is aberrant (Figure 4B). Therefore, lin-
35/Rb may play a conserved function in timing and/or
ensuring the integrity of endoreplication [50].
Components of RNAi-related pathways cooperate with 
lin-35(rr33)
The reiteration of the intestinal division pattern typical of
the L1 stage at the L2 stage in lin-35(rr33) mutants is rem-
iniscent of cell cycle abnormalities associated with hetero-
chronic mutants, which are defined by the elimination of
entire stage-specific divisions (precocious), or the reitera-
tion of events or cell divisions during larval development
(retarded) [51-55]. Control of many of the somatic cell
divisions during the L1 stage is dependent on lin-14 func-
tion and the proper transition to the second larval stage
requires the downregulation of lin-14 translation through
the action of a 22nt miRNA lin-4 [56-59]. Mutations in lin-
4 cause the reiteration of L1-specific cell division program
due to the inability to efficiently block lin-14 translation.
To determine if the lin-35(rr33) mutant phenotype could
be somehow attributed to a heterochronic defect, we per-
formed RNAi on alg-1/alg-2 (the high similarity between
alg-1 and alg-2 at the nucleotide level is likely to target
both mRNAs [60]) and dcr-1 genes, both of which were
shown to be required for lin-4 and let-7 miRNA processing
in C. elegans [60]. In wild-type animals alg-1(RNAi) or dcr-
1(RNAi) causes an significant increase in intestinal nuclei,
wherein alg-1(RNAi) has a much more pronounced effect
than dcr-1(RNAi) (Figure 5B). However, the incomplete
phenotype of dcr-1(RNAi) might be due to its essential
role in the processing of the dsRNA into smaller 21
nucleotide siRNA, or alternatively, due to the stability of
the DCR-1 protein throughout development [61].
Similar to the synMuv B genes, both alg-1  and  dcr-1
(RNAi) enhanced the intestinal phenotype of lin-35(rr33)
mutants. We found that the intestinal cells in lin-35(rr33);
alg-1(RNAi)  and  lin-35(rr33); dcr-1(RNAi) double
mutants go through several more rounds of nuclear divi-
sion than lin-35 mutants alone to become multinucleate
(Figure 5C and 5D). Some adult animals were observed
with up to 70 intestinal nuclei compared to 30 in wild
type. Because performing RNAi on components required
for the efficient execution of this pathway is not always
optimal, we tested the effect of an alg-1 null allele on the
intestinal cells. Surprisingly, the double mutant lin-
35(rr33); alg-1(gk214) is synthetic lethal, reinforcing the
idea that these two pathways interact genetically. It also
suggests that despite the very high degree of sequence sim-
ilarity between alg-1 and alg-2, alg-2 cannot compensate
for the loss of alg-1  in a lin-35(rr33)  sensitized back-
ground.
To determine whether the observed increase in the
number of intestinal nuclei could be due to the decrease
in lin-4 processing thereby causing the intestinal cells to
reiterate the L1 stage division pattern, we performed dou-
ble RNAi against alg-1 and lin-14, the known target of lin-
4. lin-14(RNAi) partially suppresses the extra nuclear divi-
sion caused by alg-1(RNAi)  in both wild-type and lin-
Table 2: cki-1 and lin-35 control progression through two different intestinal cell cycle programs during C. elegans development.
Genotype Number of intestinal nuclei ± S.D. (N)
L1 stage Adult
Wild type 20 (25) 29.4 ± 1.8 (25)
lin-35(rr33) 20 (63) 50.3 ± 4.7 (39)
cki-1(RNAi) 30.7 ± 2.8 (63) 48.8 ± 5.8 (65)
lin-35(rr33); cki-1(RNAi) 31.2 ± 2.4 (43) 92.6 ± 13.65 (45)BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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Inactivation of components in the synMuv B gene class enhances the lin-35(rr33) intestinal defect Figure 3
Inactivation of components in the synMuv B gene class enhances the lin-35(rr33) intestinal defect. (A) lin-35(rr33) animals were 
fed with bacterial clones that corresponded to the various components of the synMuv B complex and the number of intestinal 
nuclei were scored in L4 larvae 48 hrs later. The nhr-2 gene encodes a nuclear hormone receptor that has not been implicated 
in the synMuv B complex and was used as a negative control. (B) Feeding RNAi of some of the synMuv B genes was performed 
on wild-type animals and they also cause an slight increase in intestinal nuclei number, although to a lesser extent than lin-
35(rr33) alone. The asterisk denotes a Student t-Test value of < 0.05 compared to lin-35(rr33) in A and wild-type in B. (C) A 
representative example of the multinucleate intestinal cells found in double mutant lin-35(rr33); dpl-1(RNAi) and lin-35(rr33); efl-
1(RNAi) animals. The arrowheads indicate the intestinal cell boundaries. (D) The number of multinucleate cells was monitored 
in various genetic backgrounds. In wild type, all the intestinal cells of the Int3-9 rings have either 1 or 2 intestinal nuclei.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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35(rr33), but not to the levels obtained with lin-35(rr33)
alone (Figure 5A and 5B). Although we cannot rule out
the possibility that the lin-14(RNAi) does not completely
eliminate lin-14 mRNA and protein, we suggest that lin-14
downregulation by lin-4 contributes to the timely transi-
tion from karyokinesis to endoreduplication that occurs
at the end of the L1 stage.
In addition to its role in processing small RNAs in the het-
erochronic pathway, dcr-1 has also been shown to be a key
enzyme involved in RNAi pathways by processing dsRNA
into smaller, 21–22 nucleotide small interfering RNA frag-
ments (siRNA) [60]. Our findings that dcr-1(RNAi) acted
additively with lin-35 to enhance the nuclear division phe-
notype observed in the intestine motivated us to question
whether other genes of the RNAi pathway might also
genetically interact with lin-35(rr33)  to affect this cell
cycle transition. To test this possibility, we crossed lin-
35(rr33)  into a mut-7(pk204)  background, one of the
known downstream components of the RNAi pathway,
and we scored the number of intestinal nuclei [62]. As
shown in Figure 5A, mut-7(pk204)  enhanced the lin-
35(rr33)  extra nuclear division phenotype significantly
compared to lin-35(rr33) alone (p < 0.005). Since both
dcr-1(RNAi) and mut-7(pk204)  enhance the number of
extra intestinal nuclear divisions that occur in a lin-35
background, we performed RNAi against other known
RNAi components to determine if they also caused a sim-
ilar increase in the number of intestinal nuclei in combi-
nation with lin-35(rr33). We found that RNAi against mut-
14, rde-1 and  rde-4  also significantly enhanced the
number of intestinal nuclei of the lin-35(rr33) mutant,
while other components such as rde-2 did not show any
effect (Figure 4A and data not shown). We also scored the
number of intestinal nuclei per cell and we observed that
the frequency of multinucleate intestinal cells increased at
the expense of wild type cells (figure 5D). More impor-
tantly, since none of this last group of RNAi components
have been shown to be required for miRNA processing or
function, we conclude that the defects observed in their
absence in the lin-35 mutant cannot be exclusively attrib-
uted to a heterochronic defect. Although the lin-35 and
miRNA pathways may be additive, they affect the develop-
mental switch to the growth program in the intestinal cells
by independent mechanisms.
Increasing evidence suggests that the RNAi machinery
plays an important role in establishing key chromatin
modifications to allow stable repression of gene expres-
sion [63-67]. One of the best characterized modifications
is methylation of lysine 9 on histone 3. This is catalyzed
predominantly by the methyltransferase Suv39h, which
has been implicated in the initiation of heterochromatin
formation in several cell types and in different organisms
[68]. Once methylated, heterochromatin proteins (HP)
lin-35 mutants affect cyclin expression and intestinal nuclear  ploidy Figure 4
lin-35 mutants affect cyclin expression and intestinal nuclear 
ploidy. (A) qRT-PCR was performed on wild-type and lin-
35(rr33) L1 larvae and the levels of cyclin expression were 
determined compared to wild-type. The bars represent 4 
independent qRT-PCR reactions from RNA isolated from 
wild type and lin-35(rr33) animals. A positive value indicates 
an increase in gene expression compared to wild-type, while 
a negative value indicates a relative decrease in gene expres-
sion. The standard deviation is derived from the 4 independ-
ent trials. (B) DNA quantification was performed on the 
intestinal nuclei of both mutant and wild-type young adult 
hermaphrodites stained with propidium iodide. Each dia-
mond represents a lin-35(r33) mutant intestinal nucleus and 
each square represents an individual wild type intestinal 
nucleus.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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Components of the RNAi pathways cooperate with lin-35/Rb to regulate intestinal nuclear divisions Figure 5
Components of the RNAi pathways cooperate with lin-35/Rb to regulate intestinal nuclear divisions. (A) lin-35(rr33) L4 animals 
were fed with bacterial clones that corresponded to the various components of the RNAi pathways and the number of intesti-
nal nuclei was scored in L4 larvae of the next generation. (B) RNAi of some PTGS components was also performed on wild-
type worms. The asterisk denotes a Student t-Test value of < 0.05 compared to lin-35(rr33) in A and wild-type in B. (C) Exam-
ples of the multinucleate intestinal cells typically generated in the double mutants between lin-35(rr33) and various components 
of the RNAi pathways. Some cells can exceed 12 nuclei/per cell. The arrowheads indicate the intestinal cell boundaries. (D) 
The number of multinucleate cells was monitored in various genetic backgrounds. In wild type, all the intestinal cells of the 
Int3-9 rings have either 1 or 2 intestinal nuclei.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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such as HP1 recognize the modification and bind to the
methylated histone to induce conformational changes in
the chromatin typical of heterochromatin. C. elegans has
two HP1-like proteins (HPL-1 and HPL-2) and hpl-2, but
not hpl-1, was shown to be a synMuv B gene [69]. This sug-
gests that the synMuv B repressor complex may induce
chromatin changes by binding target gene promoters,
which are subsequently methylated. This step could occur
either through direct association of a methyltransferase
with the repressor complex, or in a subsequent step in
response to its binding. Recently, met-2, a predicted
meL9H3 methyltransferase, was found to behave as a syn-
Muv B class gene, reinforcing the idea that the synMuv B
genes induce transcriptional repression through chromatin
modification [70]. Consistent with this, we found that
when performed in a lin-35(rr33) mutant background, hpl-
1(RNAi), hpl-2(RNAi) as well as met-2(RNAi) increased the
number of multinucleate intestinal cells 2-, 2.5- and 3-fold,
respectively, compared to lin-35(rr33)  controls (Figure
3D). Another closely related methyltransferase, C47F5.1
had no apparent effect on intestinal cell development; cell
division or other. This suggests that met-2 is likely to be the
orthologue of Suv39h and it cooperates with lin-35/Rb and
hpl-1/hpl-2  to affect changes in gene expression. These
results argue that the LIN-35 repressor complex, which con-
tains the same synMuv B genes required for proper vulva
specification, also acts in the intestinal cell to promote this
cell cycle transition through chromatin modification.
More recently, lin-35 as well as other synMuv B genes have
been found to regulate RNAi sensitivity. The Enhancer of
RNAi (eri) genes regulate the activity of another less well
understood process that includes endoRNAi. Exactly how
these genes and lin-35/Rb may interact mechanistically to
regulate the RNAi response is still unclear [71,72]. It has
recently been proposed that dcr-1, the only C. elegans
dicer-like RNAse III, and other downstream components
of the RNAi machinery might be rate limiting. By mutat-
ing any one of the eri genes the limiting pool of active dcr-
1, as well as all the downstream components associated
with this pathway, are reallocated to the active RNAi path-
ways, therefore making them more efficient [61,73].
Evidence suggests that the lin-35 repressor complex is also
involved in a pathway that depends on the availability of
RNAi components, but is unlikely to be involved in any
functional aspect of the eri class of genes. First, double
mutant combinations of lin-35 and any of the eri genes
tested were shown to be more sensitive to RNAi than any
single mutant, suggesting that they act cooperatively and
potentially in parallel pathways [72]. Curiously, lin-35;
eri-3 or lin-35; rrf-3 have a near wild-type complement of
intestinal nuclei compared to lin-35 mutants alone, sug-
gesting that genes in the Eri pathway can suppress the
defects in the number of intestinal nuclei of the lin-35
mutant (35.2 ± 3.4 and 33.8 ± 2.5 respectively compared
to 50.3 ± 4.7 for lin-35(rr33) mutant alone). We suggest
that in an Eri background where the endoRNAi pathway
has been disabled, RNAi limiting factors are reallocated to
the synMuv B/lin-35 repressor pathway, therefore making
it more efficient. We propose that the same process may
be true to account for the enhancement of RNAi by muta-
tion in the synMuv B components as it permits the reallo-
cation of limiting levels of RNAi components to function
in the exoRNAi pathway, therefore making it more effi-
cient. Our results show that dcr-1(RNAi) enhances the lin-
35(rr33)  mutant phenotype and that by genetically
increasing the availability of RNAi components to func-
tion in the synMuv B pathway we rescue the lin-35 mutant
phenotype in the gut. We therefore propose that the syn-
Muv B pathway requires dcr-1 activity, in addition to other
downstream RNAi components, to properly repress gene
expression, potentially through a met-2-directed chroma-
tin modification.
A model for developmentally-regulated cell cycle 
transitions in the intestine
Based on our results and those of others, we propose the
following model to describe how the intestinal cell divi-
sions are controlled during C. elegans development (Fig-
ure 6A). From the specification of the E blastomere early
during development at the 12-cell stage up to the end of
embryogenesis, this precursor intestinal cell will go
through five successive rounds of mitosis to give rise to 20
intestinal cells at the hatch. This is controlled by the activ-
ity of cki-1 and perhaps other general cell cycle regulators
[29,30].
Subsequently, the posterior intestinal cells will perform a
single round of nuclear division (karyokinesis) at the end
of the L1 stage to become binucleate. Based on the intes-
tinal mutant phenotype of rr42, rr43 and rr44 as well as
the lin-5 complex, this intestinal division is likely to be
positively regulated by these genes [32]. Following these
nuclear divisions, all the intestinal cells perform succes-
sive rounds of endoreplication at each larval molt to
become polyploid by the adult stage. We and others have
shown that the transition from karyokinesis to endorepli-
cation is controlled by the lin-35/Rb repressor complex, as
well as a subclass of the RNAi components (This study
and [35]). The defect in intestinal cell cycle transition
caused by alg-1/alg-2 is at least partially due to its involve-
ment in the correct processing of lin-4, which in turn is
required for lin-14 downregulation at the end of the L1
stage. The gene product of cyd-1, cye-1 and the hetero-
chronic gene lin-4 were also shown to cause defects in the
transition from karyokinesis to endoreplication [27].
Lastly, a group of genes, like cye-1 and fzr-1, are required
for endocycling in the intestinal cells in conjunction with
each molt [74].BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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Genetic regulation of cell cycle progression in the intestinal lineage of C. elegans Figure 6
Genetic regulation of cell cycle progression in the intestinal lineage of C. elegans. (A) All the animals depicted express an intes-
tinal-specific GFP marker (elt-2::GFP), which is expressed from embryogenesis to the adult stage. The E blastomere is marked 
with a white asterisk as the transgene is not expressed at this early stage. The different types of intestinal cell cycle are marked 
under the schematic life cycle and the arrows indicate the developmental stage during which they occur. Black rectangles rep-
resent each molt. Anterior is up in all the figures and all the images are shown at the same magnification to represent the 
growth of the animal. (B) Proposed model for the lin-35/synMuv B complex in the regulation of the cell cycle transitions typical 
of the intestinal cell lineage during the L1 stage. See the text for details.BMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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Based on our data, we suggest that the lin-35 repressor
complex is required during the L1 molt to initiate the
repression of specific genes to allow the cell cycle transi-
tion typical of this lineage. Then, through a currently
uncharacterised mechanism, the production of a dsRNA
molecule specific for these genes takes place, the products
of which will feed into the RNAi pathway. Through the
action of dcr-1, these dsRNA molecules will generate
siRNA specific for these gene products that will feed back
to the chromosome to recruit met-2  and promote the
methylation of lysine 9 on histone 3. Once methylated,
both hpl-1 and hpl-2 induce the formation of heterochro-
matin to stably silence these genes (Figure 6B). This mode
of regulation may be analogous to the silencing process
observed in yeast (S. pombe) and vertebrate cells where
heterochromatin is established at the centromere through
a dsRNA-based mechanism [64,65].
Conclusion
We have shown that the simple switch from a proliferative
mode of cell cycle to one that is more consistent with
growth of the differentiated cells during development is
under very strict control and that the aberrant gene expres-
sion associated with loss of either the Rb and/or the RNAi
pathway can lead to defects in this switch. Although the
importance of lin-35/Rb in regulating the cyclins impli-
cated in this transition has been highlighted, most of the
targets of the lin-35/Rb/RNAi pathways are yet to be eluci-
dated [35]. Precisely how the components of the RNAi
pathway and Rb coordinate these processes still remains
to be characterized, but understanding how these factors




All strains were cultured according to Brenner [75]. The
following genotypes were used in this study: I: lin-
35(rr33)(this study), lin-35(n745); dpy-5(e61)unc-
29(e1072); dpy-5(e61)unc-13(e450), dpy-5(e61)unc-
13(e450); hDp41, dpy-5(e61)unc-13(e450); hDp61. II: lin-
8(n111)  dpy-10(e128). III: mut-7(pk204).V:  mut-
14(pk738). X: rrIs01 [elt-2::GFP, unc-119(+)] [30]
A genetic screen was performed using the intestinal-spe-
cific GFP (rrIs01) in order to identify mutants with abnor-
mal numbers of intestinal nuclei. In summary, staged L4
animals were mutagenized using EMS at 40 μM and
plated in order to produce the next generation. Then, 5 L4
F1 progeny were placed per plate and allow to produce
eggs. 10 plates of gravid F2 hermaphrodites were pooled
and their embryos were staged (F3). Using this approach
we screened approximately 5000 haploid genomes for
defects in the number of intestinal nuclei in the F3 gener-
ation.
Lineage analysis
lin-35(rr33); rrIs01 adult animals were allowed to produce
eggs on a seeded plate for 2–4 hours. Thereafter, newly
hatched L1 larvae were placed on individual microscope
slides which had a 2 mm thick NGM pad with a minimum
amount of bacteria. Animals were monitored every 2–3
hours using DIC and/or epifluorescence and the slides
were maintained in a humidified chamber between each
examination.
DNA quantification
DNA quantification was performed on the intestinal
nuclei by fixing the adult animals with Carnoy's solution
(60% EtOH, 30 % acetic acid and 10 % chloroform) over-
night. The nematodes were slowly rehydrated using PBS +
0.1% Tween 20. The worms were then treated with RNAse
(1 mg/ml) for 30 minutes at 37°C and stained with Pro-
pidium Iodine at 0.3 μg/ml. Z-stack series of the intestinal
nuclei were taken using a Zeiss meta confocal system and
the total number of pixels in each nucleus was determined
using Volocity (Improvision). The ploidy of the intestinal
nuclei was compared to body wall muscle nuclei.
RNA methods
Feeding RNAi experiments were performed according to
Fraser et al., 2000 [33]. In summary, L4 larvae of the cor-
responding genotypes were placed on bacteria induced
with 1 mM of IPTG. Animals were then transferred 24 hrs
later to a second plate that contained the same induced
bacteria. Intestinal nuclei were then scored 48 hrs after the
initial induction by monitoring the number of nuclei
expressing elt-2::GFP. The number of intestinal nuclei for
each RNAi experiment corresponds to 3 independent tri-
als. cki-1(RNAi) was performed as in [30].
For semi-quantitative RT-PCR (qRT-PCR) experiments,
target-specific primers for each of the corresponding genes
were designed such that the upstream primer spanned an
exon-intron boundary in order to discriminate between
the cDNA and the genomic DNA. Each primer pair was
designed to amplify regions of approximately 200 bp at
the 5' end of the gene. The targets that were examined cor-
respond to ZK507.6 (cyclin A) [rr788–rr789], ZC168.4
(cyclin B1) [rr791–rr792], Y43E12A.1 (cyclin B2.1)
[rr793–rr794], H31G24.4 (cyclin B2.2) [rr795–rr796],
T06E6.2 (cyclin B3) [rr797–rr798], Y38F1A.5 (cyclin D)
[rr785–rr787], C37A2.4 and (cyclin E) [rr782–rr783]. The
corresponding primer names are shown in the square
brackets. The levels were normalized to an actin control
(act-1, T04C12.6) [rr799–rr801], the expression of which
does not change in the various mutant backgrounds.
Total RNA was isolated from L1 stage larvae of each geno-
type using Trizol (Invitrogen). The RNA was then run over
a polyT column (Qiagen) and subsequent RT-PCR wasBMC Developmental Biology 2007, 7:38 http://www.biomedcentral.com/1471-213X/7/38
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performed on the eluate using Expand RT (Roche) (0.5–1
μg of mRNA) and a polyT primer (Invitrogen). Each PCR
reaction was performed in six replicates in 384-well PCR
plates using Hot Start Taq polymerase (Qiagen) and SYBR
green, which was used as the reporter dye and ROX as the
reference dye. The experiment was repeated 4 independ-
ent times with 4 different RT reactions. The PCR reactions
were performed on an Abiprims 7900HT real-time PCR
machine and the data were analyzed using SDS 2.1 soft-
ware provided with the machine. Primer sequences will be
provided upon request.
Microscopy and image processing
Images were captured using an ORCA ER camera (Hama-
matsu) mounted on a Leica DMR compound microscope
and processed using OpenLab software (Improvision),
following which the images were then transferred to Pho-
toshop CS for assembly.
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